Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

New immunosuppressants from Merck & Co. acting on potassium channels

July 8, 1998

Chugai to begin clinical testing of anti-IL-6 receptor antibody

July 6, 1998

Asta Medica investigates compounds for immune and allergic disorders

July 1, 1998

Human Genome Sciences presents novel chemokine, its preparation and use

July 1, 1998

Astra devotes significant resources to development of immunomodulatory peptides

June 30, 1998

Astra prepares another series of immunomodulatory peptides

June 29, 1998

Astra discloses immunomodulatory peptides for oral administration

June 26, 1998

Aviron and CSL enter collaboration for FluMist

June 26, 1998

University of Pittsburgh researcher awarded grant to study dendritic cell use in transplantation

June 26, 1998

Group C meningococcal conjugate vaccine shown safe and immunogenic in phase II

June 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...